← Back to Dashboard

Saliphenylhalamide

Human vATPase inhibitor

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1CC=CCC2=C(C(=CC=C2)O)C(=O)OC(CC1O)CC=CNC(=O)C#CC3=CC=CC=C3
FTBLSENPBXIDKK-ZZHCZQHNSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus9

Influenza A virus
FLUAV
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:21418188
Bunyamwera orthobunyavirus
BUNV
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:22910914
Alphapapillomavirus 10
HPV-6
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24614368
Alphapapillomavirus 10
HPV-11
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24614368
Alphapapillomavirus 9
HPV-16
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24614368
Alphapapillomavirus 7
HPV-18
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24614368
Alphapapillomavirus 9
HPV-31
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:24614368
Sindbis virus
SINV
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:22910914
Zika virus
ZIKV
Target: Human vATPase
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:28049006